Taylor Rachael L, Kong Jonathan, Flanagan Sean, Pogson Jacob, Croxson Glen, Pohl David, Welgampola Miriam S
Institute of Clinical Neurosciences, Royal Prince Alfred Hospital, Central Clinical School, University of Sydney, Sydney, Australia.
J Neurol. 2015 May;262(5):1228-37. doi: 10.1007/s00415-015-7697-4. Epub 2015 Mar 21.
We sought to investigate the utility of new non-invasive tests of semicircular-canal and otolith function that are usable in the neuro-otology office practice in patients with vestibular schwannoma. Fifty patients with vestibular schwannoma were assessed using a 5-item battery consisting of air-conducted cervical- and bone conducted ocular-vestibular-evoked myogenic potentials (AC cVEMPs and BC oVEMPs) and video head impulse testing (vHIT) in all three canal planes. VEMP asymmetry ratios, latencies, and vHIT gains were used to determine the test sensitivity, relationship with tumour size and the pattern of vestibular nerve involvement. The percentage of abnormalities for each of the five tests for the entire sample ranged between 36.2-61.7%. In 58.3 % of patients, test abnormalities were referable to both superior and inferior vestibular nerve divisions. Selective inferior nerve dysfunction was identified in 10.4% and superior nerve dysfunction in 12.5%. The remaining 18.8% of patients demonstrated a normal test profile. The sensitivity of the 5-item battery increased with tumour size and all patients with medium to large (>14 mm) schwannoma had at least two abnormal vestibular test result. Our results indicate that dysfunction of the superior and inferior vestibular nerve evolves in parallel for most patients with schwannoma. Unexplained vHIT and VEMP asymmetry should alert otologists and neurologists to undertake imaging in patients presenting with non-specific disequilibrium or vertigo.
我们试图研究新的半规管和耳石功能无创检测方法在神经耳科门诊实践中对前庭神经鞘瘤患者的实用性。对50例前庭神经鞘瘤患者进行了评估,使用了一个包含5项检测的组合,包括气导颈肌前庭诱发肌源性电位(AC cVEMPs)和骨导眼肌前庭诱发肌源性电位(BC oVEMPs),以及在所有三个半规管平面进行视频头脉冲测试(vHIT)。VEMP不对称率、潜伏期和vHIT增益用于确定检测敏感性、与肿瘤大小的关系以及前庭神经受累模式。整个样本的五项检测中每项检测的异常百分比在36.2%-61.7%之间。在58.3%的患者中,检测异常归因于前庭神经上、下分支。10.4%的患者被确定为选择性下神经功能障碍,12.5%的患者为上神经功能障碍。其余18.8%的患者检测结果正常。这一包含5项检测的组合的敏感性随肿瘤大小增加,所有中至大型(>14mm)神经鞘瘤患者至少有两项前庭检测结果异常。我们的结果表明,对于大多数神经鞘瘤患者,前庭神经上、下分支功能障碍是并行发展的。无法解释的vHIT和VEMP不对称应提醒耳科医生和神经科医生,对出现非特异性平衡失调或眩晕的患者进行影像学检查。